How to Buy Viridian Therapeutics Stock
Viridian Therapeutics Inc
Viridian Therapeutics, Inc. , a biotechnology company, develops treatments for patients suffering from serious diseases.
Viridian Therapeutics stock last closed at $13.81, up 4.15% from the previous day, and has decreased 51.78% in one year. It has underperformed other stocks in the Biotechnology industry by 0.31 percentage points. Viridian Therapeutics stock is currently +26.41% from its 52-week low of $10.93, and -51.29% from its 52-week high of $28.35.
As of May 1, 2024, there are 62.77M VRDN shares outstanding. The market cap of VRDN is $866.82M. In the last 24 hours, 937,581 VRDN shares were traded.
How to Buy Viridian Therapeutics Stock
Not sure how to invest in Viridian Therapeutics stock? Here's how.
- Decide where to buy Viridian Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you figure out where to buy Viridian Therapeutics stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit money your investment account: Pick your method of payment and add your information.
- Evaluate Viridian Therapeutics stock: The Viridian Therapeutics ticker symbol is VRDN. Is Viridian Therapeutics stock a good investment? Should you buy shares of VRDN? How do VRDN's underlying business fundamentals look? Do top analysts think Viridian Therapeutics is a good buy? Why has VRDN's stock price moved recently? (Hint: Our stock research website can help you evaluate if VRDN is a good stock to buy).
- Execute your VRDN buy order: Decide if you will purchase VRDN shares at the current market price or use a limit order to buy VRDN stock at a given price.
- Get notifications regarding your VRDN position: Create a watchlist to keep tabs on your investment in Viridian Therapeutics stock.
Step 1: Decide where to buy Viridian Therapeutics stock
You will need a brokerage account to access the NASDAQ market and buy VRDN shares.
Our preferred brokerage: eToro
We believe that eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world markets: From Tech to Industrials, New York to Shanghai — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro now.
Open eToro AccountStep 2: Open a brokerage account
Now that you've chosen the best brokerage, it's time to fill out some personal details so you can buy VRDN stock today.
How to Start a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to create a new trading account.
- Send your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you have finished signing up on the best stock app for beginners, your next step is to transfer the money for your investment:
Check out the tutorial below to see the process of transferring funds into your brokerage account.
Step 4: Evaluate Viridian Therapeutics stock
After you have selected the best place to buy Viridian Therapeutics stock, it's very important to research their stock before you invest, so you actually understand the risk and opportunity.
Viridian Therapeutics quick stats
VRDN Fundamentals
WallStreetZen was built to help average investors perform better fundamental analysis.
You can view all of the due diligence checks on VRDN's stock page.
Is VRDN stock undervalued or overvalued?
Analysts use many financial metrics, analyses, models, and charts to gauge VRDN's true value.
Using relative valuations methods:
- VRDN may be undervalued based on its P/B ratio of 1.96x, relative to Biotechnology industry P/B ratio of 6.02x
You can do additional valuation research on VRDN's stock here.
VRDN Financial Health Summary
Pros:
- VRDN has cash burn of 185068000. It has enough cash and short-term investments to cover this for at least one year.
- VRDN has a low debt to equity ratio of 0.11.
- There are more short-term assets than short-term liabilities on the VRDN balance sheet.
- There are more short-term assets than long-term liabilities on the VRDN balance sheet.
- Total VRDN debt is lower than 5 years ago, relative to shareholder equity.
Cons:
- VRDN profit margin has gone down from -7,329.2% to -75,711.5% in the past year.
- VRDN has $477.37M in cash and short term investments. This is not sufficient to cover its annual cash burn of $185.07M.
Is Viridian Therapeutics stock a Buy, Hold, or Sell, according to analysts?
Out of 7 sell side analysts who monitor VRDN, the consensus analyst rating on Viridian Therapeutics is a Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they financial advice.
Most Recent VRDN Analyst Upgrades/Downgrades
Gregory Renza, a top 3% analyst from RBC Capital reiterates VRDN with a buy rating and maintains their VRDN price target from $35.00 to $35.00, on Dec 14, 2023.
Jason Butler, a top 46% analyst from JMP Securities maintains VRDN with a buy rating and lowers their VRDN price target from $42.00 to $38.00, on Nov 14, 2023.
You can dig deeper into what analysts are projecting on the Viridian Therapeutics stock forecast page.
VRDN Trading Indicators
How is VRDN performing as a company?
Last year, VRDN revenue was $314.00k. Over the last five year, VRDN's revenue has gone up by -48.16% per year. This was slower than the Biotechnology industry average of 28.49%.
Dig into VRDN's earnings and revenue performance here.
Who is buying/selling VRDN?
In the last 12 months, insiders at VRDN have bought more shares than they have sold.
Fairmount Funds Management LLC, Director of VRDN, was the latest VRDN insider to buy. They bought $9,999,990.00 worth of VRDN stock on Jan 22, 2024.
Research more about who owns VRDN shares here.
Does VRDN stock generate passive income?
No, Viridian Therapeutics doesn't provide an income stream by paying out dividends.
VRDN Social Trading Data
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Execute your VRDN buy order
There are two main order types:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly the best for newer investors. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at an exact dollar amount, place a limit order.
Press the Open Trade button and your broker will place your order.
If you require additional assistance buying stocks on eToro, watch the how to video below:
Step 6: Get notifications regarding your VRDN position
Now that you own some VRDN stock, you'll want to keep up with your new investment.
Add VRDN to a watchlist to keep tabs on your VRDN stock.
VRDN Feed
How to Buy Stock in Viridian Therapeutics
To summarize, here are the 6 steps to buy Viridian Therapeutics stock:
- Decide where to buy Viridian Therapeutics stock
- Open a brokerage account
- Deposit money your investment account
- Evaluate Viridian Therapeutics stock
- Execute your VRDN buy order
- Get notifications regarding your VRDN position
If you need a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to monitor your investment in Viridian Therapeutics, create a watchlist today.
Other "How To" Guides You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.